248 related articles for article (PubMed ID: 23636058)
1. Blockade of programmed death-1 in young (New Zealand Black x New Zealand White)F1 mice promotes the suppressive capacity of CD4+ regulatory T cells protecting from lupus-like disease.
Wong M; La Cava A; Hahn BH
J Immunol; 2013 Jun; 190(11):5402-10. PubMed ID: 23636058
[TBL] [Abstract][Full Text] [Related]
2. Blockade of programmed death-1 in young (New Zealand black x New Zealand white)F1 mice promotes the activity of suppressive CD8+ T cells that protect from lupus-like disease.
Wong M; La Cava A; Singh RP; Hahn BH
J Immunol; 2010 Dec; 185(11):6563-71. PubMed ID: 21041733
[TBL] [Abstract][Full Text] [Related]
3. pConsensus peptide induces tolerogenic CD8+ T cells in lupus-prone (NZB x NZW)F1 mice by differentially regulating Foxp3 and PD1 molecules.
Singh RP; La Cava A; Hahn BH
J Immunol; 2008 Feb; 180(4):2069-80. PubMed ID: 18250412
[TBL] [Abstract][Full Text] [Related]
4. Nasal anti-CD3 antibody ameliorates lupus by inducing an IL-10-secreting CD4+ CD25- LAP+ regulatory T cell and is associated with down-regulation of IL-17+ CD4+ ICOS+ CXCR5+ follicular helper T cells.
Wu HY; Quintana FJ; Weiner HL
J Immunol; 2008 Nov; 181(9):6038-50. PubMed ID: 18941193
[TBL] [Abstract][Full Text] [Related]
5. Function of the IL-2R for thymic and peripheral CD4+CD25+ Foxp3+ T regulatory cells.
Bayer AL; Yu A; Malek TR
J Immunol; 2007 Apr; 178(7):4062-71. PubMed ID: 17371960
[TBL] [Abstract][Full Text] [Related]
6. Cellular and Molecular Phenotypes of pConsensus Peptide (pCons) Induced CD8
Singh RP; Hahn BH; Bischoff DS
Front Immunol; 2021; 12():718359. PubMed ID: 34867947
[TBL] [Abstract][Full Text] [Related]
7. Increased Foxp3(+) CD4(+) regulatory T cells with intact suppressive activity but altered cellular localization in murine lupus.
Abe J; Ueha S; Suzuki J; Tokano Y; Matsushima K; Ishikawa S
Am J Pathol; 2008 Dec; 173(6):1682-92. PubMed ID: 19008373
[TBL] [Abstract][Full Text] [Related]
8. Oral tolerance induction with antigen conjugated to cholera toxin B subunit generates both Foxp3+CD25+ and Foxp3-CD25- CD4+ regulatory T cells.
Sun JB; Raghavan S; Sjöling A; Lundin S; Holmgren J
J Immunol; 2006 Dec; 177(11):7634-44. PubMed ID: 17114433
[TBL] [Abstract][Full Text] [Related]
9. CD4(+)CD25 (+) regulatory T cells in human lupus erythematosus.
Kuhn A; Beissert S; Krammer PH
Arch Dermatol Res; 2009 Jan; 301(1):71-81. PubMed ID: 18985367
[TBL] [Abstract][Full Text] [Related]
10. Endothelial cells augment the suppressive function of CD4+ CD25+ Foxp3+ regulatory T cells: involvement of programmed death-1 and IL-10.
Bedke T; Pretsch L; Karakhanova S; Enk AH; Mahnke K
J Immunol; 2010 May; 184(10):5562-70. PubMed ID: 20382886
[TBL] [Abstract][Full Text] [Related]
11. Suppression of disease in New Zealand Black/New Zealand White lupus-prone mice by adoptive transfer of ex vivo expanded regulatory T cells.
Scalapino KJ; Tang Q; Bluestone JA; Bonyhadi ML; Daikh DI
J Immunol; 2006 Aug; 177(3):1451-9. PubMed ID: 16849451
[TBL] [Abstract][Full Text] [Related]
12. CD8+ T cell-mediated suppression of autoimmunity in a murine lupus model of peptide-induced immune tolerance depends on Foxp3 expression.
Singh RP; La Cava A; Wong M; Ebling F; Hahn BH
J Immunol; 2007 Jun; 178(12):7649-57. PubMed ID: 17548601
[TBL] [Abstract][Full Text] [Related]
13. CD4(+) CD25(+) FoxP3(+) regulatory T cells suppress cytotoxicity of CD8(+) effector T cells: implications for their capacity to limit inflammatory central nervous system damage at the parenchymal level.
Göbel K; Bittner S; Melzer N; Pankratz S; Dreykluft A; Schuhmann MK; Meuth SG; Wiendl H
J Neuroinflammation; 2012 Feb; 9():41. PubMed ID: 22373353
[TBL] [Abstract][Full Text] [Related]
14. Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4
Polanczyk MJ; Walker E; Haley D; Guerrouahen BS; Akporiaye ET
J Transl Med; 2019 Jul; 17(1):219. PubMed ID: 31288845
[TBL] [Abstract][Full Text] [Related]
15. CD4+CD25+FoxP3+PD1- regulatory T cells in acute and stable relapsing-remitting multiple sclerosis and their modulation by therapy.
Saresella M; Marventano I; Longhi R; Lissoni F; Trabattoni D; Mendozzi L; Caputo D; Clerici M
FASEB J; 2008 Oct; 22(10):3500-8. PubMed ID: 18587005
[TBL] [Abstract][Full Text] [Related]
16. Y27, a novel derivative of 4-hydroxyquinoline-3-formamide, prevents the development of murine systemic lupus erythematosus-like diseases in MRL/lpr autoimmune mice and BDF1 hybrid mice.
Xiao ZY; Chen SH; Cheng JP; Zhou WX; Zhang YX; Yang RF; Yun LH
Arthritis Res Ther; 2012 Nov; 14(6):R235. PubMed ID: 23116248
[TBL] [Abstract][Full Text] [Related]
17. Tumor evasion of the immune system by converting CD4+CD25- T cells into CD4+CD25+ T regulatory cells: role of tumor-derived TGF-beta.
Liu VC; Wong LY; Jang T; Shah AH; Park I; Yang X; Zhang Q; Lonning S; Teicher BA; Lee C
J Immunol; 2007 Mar; 178(5):2883-92. PubMed ID: 17312132
[TBL] [Abstract][Full Text] [Related]
18. Bcl-xL is required for the development of functional regulatory CD4 cells in lupus-afflicted mice following treatment with a tolerogenic peptide.
Sharabi A; Lapter S; Mozes E
J Autoimmun; 2010 Mar; 34(2):87-95. PubMed ID: 19596183
[TBL] [Abstract][Full Text] [Related]
19. CD5 plays an inhibitory role in the suppressive function of murine CD4(+) CD25(+) T(reg) cells.
Dasu T; Qualls JE; Tuna H; Raman C; Cohen DA; Bondada S
Immunol Lett; 2008 Aug; 119(1-2):103-13. PubMed ID: 18573278
[TBL] [Abstract][Full Text] [Related]
20. IL-2/anti-IL-2 complexes ameliorate lupus nephritis by expansion of CD4
Yan JJ; Lee JG; Jang JY; Koo TY; Ahn C; Yang J
Kidney Int; 2017 Mar; 91(3):603-615. PubMed ID: 27914701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
